Sana Biotechnology (SANA) Intangibles (2020 - 2026)
Sana Biotechnology (SANA) posted Intangibles of $59.2 million for Q1 2026, little changed sequentially from $59.2 million in Q4 2025, and little changed YoY from $59.2 million in Q1 2025.
Sana Biotechnology (SANA) Intangibles (2020 - 2026) Analysis & Trends
Sana Biotechnology has reported Intangibles for 7 years, with the latest figure at $59.2 million in Q1 2026.
- Quarterly Intangibles changed 0.0% year-over-year to $59.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.2 million (changed 0.0% YoY) and the FY2025 annual result came in at $59.2 million, changed 0.0% from the prior year.
- Intangibles held at $59.2 million in Q1 2026 per SANA's latest filing, from $59.2 million in the prior quarter.
- Over five years, Intangibles peaked at $59.2 million in Q1 2022 and troughed at $59.2 million in Q1 2022.
- A 5-year average of $59.2 million and a median of $59.2 million in 2022 frame the typical range for Intangibles.
- The widest YoY moves for Intangibles: up 0.0% in 2022, down 0.01% in 2022.
- Over 5 years, Intangibles stood at $59.2 million in 2022, then changed by 0.0% to $59.2 million in 2023, then changed by 0.0% to $59.2 million in 2024, then changed by 0.0% to $59.2 million in 2025, then changed by 0.0% to $59.2 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $59.2 million, $59.2 million, and $59.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Sana Biotechnology | 1.06 Bn | 1.06 Bn | - | 59.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.20 Mn |
| Mar 31, 2026 | 59.20 Mn |
| Dec 31, 2025 | 59.20 Mn |
| Sep 30, 2025 | 59.20 Mn |
| Jun 30, 2025 | 59.20 Mn |
| Mar 31, 2025 | 59.20 Mn |
| Dec 31, 2024 | 59.20 Mn |
| Sep 30, 2024 | 59.20 Mn |
| Jun 30, 2024 | 59.20 Mn |
| Mar 31, 2024 | 59.20 Mn |
| Dec 31, 2023 | 59.20 Mn |
| Sep 30, 2023 | 59.20 Mn |
| Jun 30, 2023 | 59.20 Mn |
| Mar 31, 2023 | 59.20 Mn |
| Dec 31, 2022 | 59.20 Mn |
| Sep 30, 2022 | 59.20 Mn |
| Jun 30, 2022 | 59.20 Mn |
| Mar 31, 2022 | 59.20 Mn |
| Dec 31, 2021 | 59.20 Mn |
| Sep 30, 2021 | 59.20 Mn |